TCAs with predominantly SRI actions vs other TCAsWithdrawals due to adverse events · adults with trichotillomania1 finding from 1 reviewPharmacotherapy for trichotillomania 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 26 participantsLow